Case Study: Bogardus Medical Systems achieves Meaningful Use certification and EPCS-compliant e-prescribing with DrFirst

Adding Award-Winning E-prescribing and Controlled Substance E-prescribing to Achieve MU Certification

Bogardus Medical Systems (BMSi), developer of the ONCOCHART EMR used primarily by oncologists, faced the challenge of adding a compliant e‑prescribing solution to meet CMS/AARA HITECH Act Meaningful Use requirements without diverting resources to build and maintain the system in‑house. They sought a partner that offered ease of use for clinicians, a simple integration for developers, and strong ongoing support.

BMSi selected DrFirst after vetting vendors and integrated its Rcopia® e‑prescribing and EPCS GoldSM 2.0 controlled‑substance solution, which DrFirst pre‑certified with Surescripts. The partnership allowed BMSi to certify ONCOCHART on time and on budget, provide a certified, user‑friendly e‑prescribing capability tailored to oncologists, and avoid significant development and maintenance costs.

Bogardus Medical Systems

Jeffrey Carlin

Chief Operations Officer